What the PCOS name change says about a misunderstood syndrome Long framed as a gynecological condition, PMOS is now understood as a multisystem disorder with metabolic, psychological, and cardiovascular consequences. Written byBree Foster, PhD

https://www.drugdiscoverynews.com/what-the-pcos-name-change-says-about-a-misunderstood-syndrome-17250 In May, one of medicine’s most common — and most misunderstood — hormonal conditions took on a new name. Polycystic ovary syndrome, long known as PCOS, is now being rebranded as polyendocrine metabolic ovarian syndrome, or PMOS. The change reflects decades of evidence showing that ovarian cysts are neither universal nor central to the condition, and brings its underlying endocrine and metabolic dysfunction into clearer focus. Advocates hope that this rebrand will improve diagnosis, shift clinical focus beyond reproduction, and catalyze research into disease-modifying therapies that have remained elusive for decades.